These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 19384955)
21. DJ-1, a novel regulator of the tumor suppressor PTEN. Kim RH; Peters M; Jang Y; Shi W; Pintilie M; Fletcher GC; DeLuca C; Liepa J; Zhou L; Snow B; Binari RC; Manoukian AS; Bray MR; Liu FF; Tsao MS; Mak TW Cancer Cell; 2005 Mar; 7(3):263-73. PubMed ID: 15766664 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of hTERT expression by MAP kinase inhibitor induces cell death in renal cell carcinoma. Pal D; Sharma U; Singh SK; Kakkar N; Prasad R Urol Oncol; 2017 Jun; 35(6):401-408. PubMed ID: 28215740 [TBL] [Abstract][Full Text] [Related]
23. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression. Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954 [TBL] [Abstract][Full Text] [Related]
24. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase. Stefanou N; Papanikolaou V; Furukawa Y; Nakamura Y; Tsezou A BMC Cancer; 2010 Aug; 10():442. PubMed ID: 20723213 [TBL] [Abstract][Full Text] [Related]
25. The positive correlation between DJ-1 and β-catenin expression shows prognostic value for patients with glioma. Wang C; Fang M; Zhang M; Li W; Guan H; Sun Y; Xie S; Zhong X Neuropathology; 2013 Dec; 33(6):628-36. PubMed ID: 23714193 [TBL] [Abstract][Full Text] [Related]
26. A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data. Zhao H; Leppert JT; Peehl DM PLoS One; 2016; 11(1):e0146505. PubMed ID: 26814892 [TBL] [Abstract][Full Text] [Related]
27. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277 [TBL] [Abstract][Full Text] [Related]
28. Effect of DJ-1 overexpression on the proliferation, apoptosis, invasion and migration of laryngeal squamous cell carcinoma SNU-46 cells through PI3K/AKT/mTOR. Wang B; Qin H; Wang Y; Chen W; Luo J; Zhu X; Wen W; Lei W Oncol Rep; 2014 Sep; 32(3):1108-16. PubMed ID: 24969178 [TBL] [Abstract][Full Text] [Related]
29. Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway. Chen J; Zhu H; Zhang Y; Cui MH; Han LY; Jia ZH; Wang L; Teng H; Miao LN Mol Med Rep; 2015 Aug; 12(2):2622-8. PubMed ID: 25954860 [TBL] [Abstract][Full Text] [Related]
30. Relevance and therapeutic possibility of PTEN-long in renal cell carcinoma. Wang H; Zhang P; Lin C; Yu Q; Wu J; Wang L; Cui Y; Wang K; Gao Z; Li H PLoS One; 2015; 10(2):e114250. PubMed ID: 25714556 [TBL] [Abstract][Full Text] [Related]
31. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival. Du P; Ye L; Yang Y; Jiang WG Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253 [TBL] [Abstract][Full Text] [Related]
32. Overexpression of the Parkinson disease protein DJ-1 and its regulator PTEN in gestational trophoblastic disease. Zhang HJ; Siu MK; Jiang LL; Mak VC; Ngan HY; Cheung AN Int J Gynecol Pathol; 2010 Sep; 29(5):468-75. PubMed ID: 20736773 [TBL] [Abstract][Full Text] [Related]
33. Tumor suppressive microRNA‑429 regulates cellular function by targeting VEGF in clear cell renal cell carcinoma. Chen D; Li Y; Li Y; Jin L; Su Z; Yu Z; Yang S; Mao X; Lai Y Mol Med Rep; 2016 Feb; 13(2):1361-6. PubMed ID: 26647818 [TBL] [Abstract][Full Text] [Related]
34. The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels. Zhou C; Bae-Jump VL; Whang YE; Gehrig PA; Boggess JF Gynecol Oncol; 2006 May; 101(2):305-10. PubMed ID: 16380156 [TBL] [Abstract][Full Text] [Related]
35. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Furge KA; Chen J; Koeman J; Swiatek P; Dykema K; Lucin K; Kahnoski R; Yang XJ; Teh BT Cancer Res; 2007 Apr; 67(7):3171-6. PubMed ID: 17409424 [TBL] [Abstract][Full Text] [Related]
36. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor. Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177 [TBL] [Abstract][Full Text] [Related]
37. Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma. Cooper SJ; Zou H; Legrand SN; Marlow LA; von Roemeling CA; Radisky DC; Wu KJ; Hempel N; Margulis V; Tun HW; Blobe GC; Wood CG; Copland JA Oncogene; 2010 May; 29(20):2905-15. PubMed ID: 20208565 [TBL] [Abstract][Full Text] [Related]
39. In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself. Breuksch I; Welter J; Bauer HK; Enklaar T; Frees S; Thüroff JW; Hasenburg A; Prawitt D; Brenner W Cell Commun Signal; 2018 Jun; 16(1):35. PubMed ID: 29954386 [TBL] [Abstract][Full Text] [Related]
40. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma. Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]